AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31302767 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cryotherapy during the second half of the course of cytotoxic agents administration (arm B)
Number of subjects: 145
Study 31302767 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular oral cryotherapy twice a day (arm C)
Number of subjects: 145
Study 31302767 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral care without cryotherapy (arm D)
Number of subjects: 145
Study 29733492 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) training
Number of subjects: 62
Study 29733492 — intervention group
Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 62
Study 30645838 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Quyu Recipe (BQR) combined with acupuncture
Number of subjects: 170
Study 30645838 — intervention group
Group type: COMPARATOR
Intervention: Cold needle puncture drainage operation alone (Control)
Number of subjects: 170
Study 23860288 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate supplementation (0.5 g·kg·h)
Number of subjects: 12
Study 23860288 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 24032187 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture prescription of regulating yin-yang and five viscera
Number of subjects: 700
Study 24032187 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture prescription of tranquilizing mind
Number of subjects: 700
Study 24032187 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 700
Study 20942276 — intervention group
Group type: EXPERIMENTAL
Intervention: Catgut implantation at Hanyan (GB 4), Baihui (GV 20), Shenmen (HT 7), Fenglong (ST 40), Taichong (LR 3), once every two weeks, for a total of 4 times.
Number of subjects: 94
Study 20942276 — intervention group
Group type: COMPARATOR
Intervention: Deanxit, oral administration for eight weeks.
Number of subjects: 94
Study 18769066 — intervention group
Group type: EXPERIMENTAL
Intervention: ORS + 25 g PHGG
Number of subjects: 195
Study 18769066 — intervention group
Group type: EXPERIMENTAL
Intervention: ORS + 50 g PHGG
Number of subjects: 195
Study 18769066 — intervention group
Group type: COMPARATOR
Intervention: ORS alone (control)
Number of subjects: 195
Study 16948480 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (1.2 g/kg body mass whey protein + 0.3 g/kg body mass sucrose powder, N = 9: 6 female, 3 male)
Number of subjects: 27
Study 16948480 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein (1.2 g/kg body mass soy protein + 0.3 g/kg body mass sucrose powder, N = 9: 6 female, 3 male)
Number of subjects: 27
Study 16948480 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1.2 g/kg body mass maltodextrin + 0.3 g/kg body mass sucrose powder, N = 9: 6 female, 3 male)
Number of subjects: 27
Study 14514574 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (2 g/day) for 4 weeks
Number of subjects: 39
Study 14514574 — intervention group
Group type: COMPARATOR
Intervention: Control (no antioxidant)
Number of subjects: 39
Study 10880891 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg micronised fenofibrate
Number of subjects: 340
Study 10880891 — intervention group
Group type: EXPERIMENTAL
Intervention: 267 mg micronised fenofibrate
Number of subjects: 340
Study 10880891 — intervention group
Group type: EXPERIMENTAL
Intervention: 340 mg micronised fenofibrate
Number of subjects: 340
Study 10880891 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg micronised fenofibrate
Number of subjects: 340
Study 10880891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 8769284 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 120 mg four times a day for four weeks combined with metronidazole 250 mg four times a day for one week (group A, N = 21)
Number of subjects: 41
Study 8769284 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo (group B, N = 20)
Number of subjects: 41
Study 1570227 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release morphine 30-mg tablets (MSC) administered rectally
Number of subjects: 14
Study 1570227 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release morphine 30-mg suppositories (RMS)
Number of subjects: 14
Study 1570227 — intervention group
Group type: COMPARATOR
Intervention: Controlled-release morphine 30-mg tablets (MSC) administered orally
Number of subjects: 14
Study 6399444 — intervention group
Group type: EXPERIMENTAL
Intervention: Four drugs commonly used for pain relief (specific drugs not mentioned)
Number of subjects: 1000
Study 6399444 — intervention group
Group type: COMPARATOR
Intervention: Cost and safety considerations
Number of subjects: 1000
Study 30820733 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of fractures
Number of subjects: 158
Study 30820733 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of fractures
Number of subjects: 158
Study 30820733 — intervention group
Group type: EXPERIMENTAL
Intervention: Location of fractures
Number of subjects: 158
Study 29177589 — intervention group
Group type: EXPERIMENTAL
Intervention: Core needle biopsy under ultrasound guidance prior to RFVTA
Number of subjects: 24
Study 29177589 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic radiofrequency volumetric thermal ablation (RFVTA)
Number of subjects: 24
Study 29177589 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic myomectomy
Number of subjects: 24
Study 26891840 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP for the general population
Number of subjects: 154
Study 26891840 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP for gay men
Number of subjects: 154
Study 26891840 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP for Black gay men
Number of subjects: 154
Study 26891840 — intervention group
Group type: COMPARATOR
Intervention: Prejudice levels
Number of subjects: 154
Study 24015787 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Weight‐Loss trial (induced 2% dehydration)
Number of subjects: 8
Study 24015787 — intervention group
Group type: COMPARATOR
Intervention: Control trial (euhydration maintained)
Number of subjects: 8
Study 24015787 — intervention group
Group type: EXPERIMENTAL
Intervention: Both trials
Number of subjects: 8
Study 23012344 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (one 50 min Dru Yoga session each week for 8 weeks and a 20 min DVD for home practice)
Number of subjects: 74
Study 23012344 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 74
Study 20382637 — intervention group
Group type: EXPERIMENTAL
Intervention: Toremifene
Number of subjects: 243
Study 20382637 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 243
Study 17429632 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous 6-hour infusion of l-HOP (oxaliplatin)
Number of subjects: 64
Study 17429632 — intervention group
Group type: COMPARATOR
Intervention: Conventional 2-hour infusion of l-HOP (oxaliplatin)
Number of subjects: 64
Study 16125590 — intervention group
Group type: EXPERIMENTAL
Intervention: T-cell depleted marrow and cyclosporine A (TCD arm; n=201)
Number of subjects: 405
Study 16125590 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate and cyclosporine A after transplantation of T-replete marrow (M/C arm; n=204)
Number of subjects: 405
Study 16125590 — intervention group
Group type: EXPERIMENTAL
Intervention: T-cell depleted marrow and cyclosporine A (TCD arm)
Number of subjects: 405
Study 14522768 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal ACR6D
Number of subjects: 88
Study 14522768 — intervention group
Group type: EXPERIMENTAL
Intervention: AMO SI40NB
Number of subjects: 88
Study 14522768 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroview H60M
Number of subjects: 88
Study 14522768 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof MA60BM
Number of subjects: 88
Study 10822287 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice
Number of subjects: 9
Study 10822287 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry juice
Number of subjects: 9
Study 10822287 — intervention group
Group type: COMPARATOR
Intervention: Sucrose solution (control)
Number of subjects: 9
Study 8860096 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin sensitivity index (S(I))
Number of subjects: 64
Study 8860096 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure
Number of subjects: 64
Study 8860096 — intervention group
Group type: EXPERIMENTAL
Intervention: A(2) allele of glycogen synthase
Number of subjects: 64
Study 1513926 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 percent nitrous oxide in oxygen
Number of subjects: 30
Study 1513926 — intervention group
Group type: COMPARATOR
Intervention: 100 percent oxygen
Number of subjects: 30
Study 6376229 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g, trimipramine 50 mg, prostaglandin E1 analogue 800 or 200 micrograms, low-dose antacid or placebo (antiulcer treatment)
Number of subjects: 197
Study 31127611 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal trabecular bone reconstruction system
Number of subjects: 66
Study 31127611 — intervention group
Group type: COMPARATOR
Intervention: Free vascularized fibular graft
Number of subjects: 66
Study 28270285 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated tube potential selection technique with a preferred image quality of 288 mA/100 kV (Group 1)
Number of subjects: 59
Study 28270285 — intervention group
Group type: COMPARATOR
Intervention: Tube voltage of 100 kV with automated tube current modulation using a reference tube current of 288 mA (Group 2)
Number of subjects: 59
Study 28270285 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 59
Study 26810483 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 130/0.42 (HES)
Number of subjects: 208
Study 26810483 — intervention group
Group type: COMPARATOR
Intervention: Ringer acetate
Number of subjects: 208
Study 25060950 — intervention group
Group type: EXPERIMENTAL
Intervention: B0.25 group (3.75mg hyperbaric bupivacaine 2.5mg/ml)
Number of subjects: 66
Study 25060950 — intervention group
Group type: COMPARATOR
Intervention: B0.5 group (7.5mg hyperbaric bupivacaine 5mg/ml)
Number of subjects: 66
Study 22659390 — intervention group
Group type: EXPERIMENTAL
Intervention: SmokingZine website access for 1 hour per day during camp
Number of subjects: 52
Study 22659390 — intervention group
Group type: COMPARATOR
Intervention: Control group (no access to the website)
Number of subjects: 52
Study 22659390 — intervention group
Group type: EXPERIMENTAL
Intervention: SmokingZine website access
Number of subjects: 52
Study 21058572 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher identifiers primed with an out-group
Number of subjects: 0
Study 21058572 — intervention group
Group type: COMPARATOR
Intervention: Higher identifiers primed with the in-group
Number of subjects: 0
Study 17414592 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofibrate 100 mg daily for 8 weeks
Number of subjects: 75
Study 17414592 — intervention group
Group type: COMPARATOR
Intervention: Control (AHA Step II diet and physical activity)
Number of subjects: 75
Study 15780695 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex (valproate, Depakote)
Number of subjects: 25
Study 15780695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 11369834 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of established severe anaemia in patients with ESRD
Number of subjects: 0
Study 11369834 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention in haemodynamic risk factors (anaemia and hypertension)
Number of subjects: 0
Study 11369834 — intervention group
Group type: EXPERIMENTAL
Intervention: Late intervention to normalize haemoglobin
Number of subjects: 0
Study 10214563 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug X
Number of subjects: 32
Study 10214563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 7824584 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing bear (BrBr)
Number of subjects: 36
Study 7824584 — intervention group
Group type: COMPARATOR
Intervention: Non-breathing bear (N-BrBr)
Number of subjects: 36
Study 3578724 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation using nitrous oxide with halothane (group 1)
Number of subjects: 0
Study 3578724 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation using isoflurane (group 2)
Number of subjects: 0
Study 3578724 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled ventilation with atracurium (group 3)
Number of subjects: 0
Study 30212281 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery incentive intervention
Number of subjects: 100
Study 26968272 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine infiltration (20ml of 0.25% plain)
Number of subjects: 80
Study 26968272 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bupivacaine infiltration)
Number of subjects: 80
Study 23812594 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy for 8 months
Number of subjects: 119
Study 22506497 — intervention group
Group type: EXPERIMENTAL
Intervention: Local sequential context provided by preceding facial expressions
Number of subjects: 0
Study 22506497 — intervention group
Group type: EXPERIMENTAL
Intervention: Preceding facial expressions
Number of subjects: 0
Study 22032056 — intervention group
Group type: EXPERIMENTAL
Intervention: Externally irrigated-tip catheter (n = 25; 45 degrees C/40 W outside the coronary sinus and 45 degrees C/30 W inside the coronary sinus)
Number of subjects: 50
Study 22032056 — intervention group
Group type: COMPARATOR
Intervention: Conventional-tip catheter (n = 25; 60 degrees C/60 W outside and 55 degrees C/35 W inside the coronary sinus)
Number of subjects: 50
Study 18070186 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral polyoestradiol phosphate (PEP) therapy (240 mg/month)
Number of subjects: 234
Study 18070186 — intervention group
Group type: COMPARATOR
Intervention: Orchidectomy
Number of subjects: 234
Study 17071428 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotomy
Number of subjects: 128
Study 17071428 — intervention group
Group type: COMPARATOR
Intervention: No amniotomy (Control)
Number of subjects: 128
Study 12947426 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (reductions in total fat and refined carbohydrates, increased n‐3 over n‐6 plus saturated fatty acids, increased intake of dietary fibre and phytooestrogens)
Number of subjects: 99
Study 12947426 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 99
Study 10868707 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-interval group (14-35 days between tests)
Number of subjects: 53
Study 10868707 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-interval group (40-180 days between tests)
Number of subjects: 53
Study 10868707 — intervention group
Group type: EXPERIMENTAL
Intervention: All subjects
Number of subjects: 53
Study 9357378 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray (2 sprays per nostril bid)
Number of subjects: 233
Study 9357378 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 233
Study 8238830 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2 mg.kg‐1 and Alfentanil 50 micrograms.kg‐1
Number of subjects: 0
Study 8238830 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone 5 mg.kg‐1 and Suxamethonium 1 mg.kg‐1
Number of subjects: 0
Study 6354230 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. infusion of insulin, 70 mu. kg‐1h‐1 for the first 60 min and 35 mu. kg‐1h‐1 subsequently
Number of subjects: 0
Study 6354230 — intervention group
Group type: COMPARATOR
Intervention: Control group of patients
Number of subjects: 0
Study 31403570 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact exercises from the OPTIMA-Ex trial
Number of subjects: 15
Study 30488952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive Glass (BG) with autologous platelet-rich fibrin (PRF)
Number of subjects: 20
Study 30488952 — intervention group
Group type: COMPARATOR
Intervention: Bioactive Glass (BG) alone
Number of subjects: 20
Study 26965908 — intervention group
Group type: EXPERIMENTAL
Intervention: University-wide bystander behavior intervention consisting of a 30-min presentation on dating violence and a week-long 'red flag' social marketing campaign
Number of subjects: 329
Study 26965908 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 329
Study 27239994 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcysteine (A)
Number of subjects: 75
Study 27239994 — intervention group
Group type: COMPARATOR
Intervention: Standard oral management (S)
Number of subjects: 75
Study 25104916 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg)
Number of subjects: 160
Study 25104916 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (4 mg)
Number of subjects: 160
Study 25104916 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (8 mg)
Number of subjects: 160
Study 22661278 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-intensity modified constraint-induced movement therapy (mCIMT)
Number of subjects: 66
Study 22661278 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 66
Study 19358788 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (80 mg daily)
Number of subjects: 32
Study 19358788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 19358788 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 32
Study 17666600 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ferric carboxymaltose (less than or equal to 1,000 mg over 15 minutes, repeated weekly)
Number of subjects: 352
Study 17666600 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ferric carboxymaltose
Number of subjects: 352
Study 17666600 — intervention group
Group type: COMPARATOR
Intervention: Oral ferrous sulfate (FeSO(4) 325 mg orally thrice daily for 6 weeks)
Number of subjects: 352
Study 16508277 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine‐gluconate (2%)‐based cavity disinfectant
Number of subjects: 35
Study 16508277 — intervention group
Group type: COMPARATOR
Intervention: No disinfectant treatment (Control)
Number of subjects: 35
Study 15567628 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 0
Study 15567628 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 15567628 — intervention group
Group type: EXPERIMENTAL
Intervention: Low physical functioning and low global health status and quality of life
Number of subjects: 0
Study 10852195 — intervention group
Group type: EXPERIMENTAL
Intervention: Hewlett Packard (HP) monitoring system
Number of subjects: 16
Study 10852195 — intervention group
Group type: COMPARATOR
Intervention: Kontron Instruments (KI) monitoring system
Number of subjects: 16
Study 10852195 — intervention group
Group type: COMPARATOR
Intervention: Marquette‐Hellige (MH) monitoring system
Number of subjects: 16
Study 8814685 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin 400 mg/m2 as a single agent (CB)
Number of subjects: 130
Study 8814685 — intervention group
Group type: COMPARATOR
Intervention: Combination of carboplatin 300 mg/m2, epirubicin 50 mg/m2 and cyclophosphamide 500 mg/m2 (CB‐EC)
Number of subjects: 130
Study 8814685 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 130
Study 1856402 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery
Number of subjects: 174
Study 1856402 — intervention group
Group type: COMPARATOR
Intervention: No ischemia (postoperative)
Number of subjects: 174
Study 1856402 — intervention group
Group type: COMPARATOR
Intervention: Silent ischemia (postoperative)
Number of subjects: 174
Study 1856402 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic ischemia (postoperative)
Number of subjects: 174
Study 6416576 — intervention group
Group type: EXPERIMENTAL
Intervention: 111In granulocyte scanning
Number of subjects: 22
Study 30898134 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE) supplementation
Number of subjects: 16
Study 30898134 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 16
Study 28648477 — intervention group
Group type: EXPERIMENTAL
Intervention: Early antibiotic administration (mean TTA 4.35h, 58.5% received first dose within 4h)
Number of subjects: 371
Study 25714493 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive urodynamic testing
Number of subjects: 222
Study 25714493 — intervention group
Group type: COMPARATOR
Intervention: Clinical assessment with non‐invasive tests (control arm)
Number of subjects: 222
Study 23331192 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal oestradiol (plus cyclic medroxyprogesterone) for 12 months
Number of subjects: 69
Study 23331192 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 69
Study 21639818 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week HF diet intervention
Number of subjects: 17
Study 21639818 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week HF diet intervention
Number of subjects: 17
Study 16850522 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (50 mg/day)
Number of subjects: 13
Study 16850522 — intervention group
Group type: COMPARATOR
Intervention: Clozapine (450 mg/day)
Number of subjects: 13
Study 12897981 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace set at -5 degrees
Number of subjects: 44
Study 12897981 — intervention group
Group type: COMPARATOR
Intervention: Straight brace (0 degrees)
Number of subjects: 44
Study 11099588 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey hydrolysate formula (n = 23)
Number of subjects: 43
Study 11099588 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (n = 20)
Number of subjects: 43
Study 8871187 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (hGH) treatment for 2 years
Number of subjects: 25
Study 8871187 — intervention group
Group type: COMPARATOR
Intervention: Before treatment
Number of subjects: 25
Study 8871187 — intervention group
Group type: EXPERIMENTAL
Intervention: After 2 years of hGH treatment
Number of subjects: 25
Study 1642487 — intervention group
Group type: EXPERIMENTAL
Intervention: Model A of discharge planning rounds
Number of subjects: 0